Cleared Traditional

K123581 - NELLCOR OXIMAX N-600X PULSE OXIMETER

K123581 is an FDA 510(k) clearance for NELLCOR OXIMAX N-600X PULSE OXIMETER, manufactured by Covidien, Formerly Nellcor Puritan Bennett, Inc.. The device is a Class 2 Anesthesiology device with product code DQA cleared through the Traditional 510(k) pathway after a 170-day FDA review.

K123581 · Covidien, Formerly Nellcor Puritan Bennett, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2013
Decision
170d
Days
Class 2
Risk

K123581 is an FDA 510(k) clearance for the NELLCOR OXIMAX N-600X PULSE OXIMETER, NELLCOR BEDSIDE RESPIRATORY PATIENT MON.... Classified as Oximeter (product code DQA), Class II - Special Controls.

Submitted by Covidien, Formerly Nellcor Puritan Bennett, Inc. (Boulder, US). The FDA issued a Cleared decision on May 9, 2013 after a review of 170 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 870.2700 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Covidien, Formerly Nellcor Puritan Bennett, Inc. devices

FDA 510(k) Submission Details - K123581

510(k) Number K123581 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 20, 2012
Decision Date May 09, 2013
Days to Decision 170 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
30d slower than avg
Panel avg: 140d · This submission: 170d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQA Device Classification - Class 2, Special Controls

Product Code DQA Oximeter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2700
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - DQA Oximeter

All 454
Devices cleared under the same product code (DQA) and FDA review panel - the closest regulatory comparables to K123581.
IHEALTH FINGERTIP PULSE OXIMETER
K131111 · Andon Health Co, Ltd. · Sep 2013
VITAL SIGNS MONITOR
K131818 · Edan Instruments, Inc. · Aug 2013
FINGERTIP PULSE OXIMETER
K123871 · Beijing Choice Electronic Technololgy Co., Ltd. · May 2013
MASIMO RAS-125C ACOUSTIC RESPIRATION SENSOR
K120984 · Masimo Corporation · Apr 2013
WRIST PULSE OXIMETER
K122046 · Beijing Choice Electronic Technololgy Co., Ltd. · Feb 2013
FINGERTIP PULSE OXIMETER
K121697 · Andon Health Co, Ltd. · Oct 2012